Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 220

1.

erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia.

Yang JM, Shen CJ, Chen XJ, Kong Y, Liu YS, Li XW, Chen Z, Gao TM, Li XM.

Cereb Cortex. 2018 Dec 22. doi: 10.1093/cercor/bhy316. [Epub ahead of print]

PMID:
30590426
2.

Low Field Magnetic Stimulation Ameliorates Schizophrenia-Like Behavior and Up-Regulates Neuregulin-1 Expression in a Mouse Model of Cuprizone-Induced Demyelination.

Sun Z, Jiang T, Wu Y, Ma C, He Y, Yang J.

Front Psychiatry. 2018 Dec 6;9:675. doi: 10.3389/fpsyt.2018.00675. eCollection 2018.

3.

ErbB4 Receptors in the Medial Habenula Regulate Contextual Fear Memory.

Geng F, Liu JY, Chen XW, Zou WJ, Wu JL, Rodriguez G, Peng C, Tian J, Lu GF.

Pharmacology. 2018 Dec 4;103(1-2):68-75. doi: 10.1159/000495064. [Epub ahead of print]

PMID:
30513516
4.

Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice.

Wang H, Liu F, Chen W, Sun X, Cui W, Dong Z, Zhao K, Zhang H, Li H, Xing G, Fei E, Pan BX, Li BM, Xiong WC, Mei L.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13105-13110. doi: 10.1073/pnas.1811287115. Epub 2018 Nov 29.

PMID:
30498032
5.

Ablation of ErbB4 in parvalbumin-positive interneurons inhibits adult hippocampal neurogenesis through down-regulating BDNF/TrkB expression.

Zhang H, He X, Mei Y, Ling Q.

J Comp Neurol. 2018 Oct 15;526(15):2482-2492. doi: 10.1002/cne.24506. Epub 2018 Oct 17.

PMID:
30329159
6.

Leveraging genome-wide association and clinical data in revealing schizophrenia subgroups.

Yin L, Cheung EF, Chen RY, Wong EH, Sham PC, So HC.

J Psychiatr Res. 2018 Nov;106:106-117. doi: 10.1016/j.jpsychires.2018.09.010. Epub 2018 Sep 22.

PMID:
30312963
7.

Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders.

Chung DW, Chung Y, Bazmi HH, Lewis DA.

Neuropsychopharmacology. 2018 Nov;43(12):2478-2486. doi: 10.1038/s41386-018-0169-7. Epub 2018 Aug 2.

PMID:
30120408
8.

Assessment of a combination of Serum Proteins as potential biomarkers to clinically predict Schizophrenia.

Li C, Tao H, Yang X, Zhang X, Liu Y, Tang Y, Tang A.

Int J Med Sci. 2018 Jun 4;15(9):900-906. doi: 10.7150/ijms.24346. eCollection 2018.

9.

Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice.

Dominguez SL, Hegde GV, Hanson JE, Xiang H, Mandikian D, Boswell CA, Chiu C, Wu Y, Tsai SP, Fleck D, Weber M, Ngu H, Scearce-Levie K, Jackson EL.

Sci Rep. 2018 May 29;8(1):8239. doi: 10.1038/s41598-018-26492-4.

10.

Neuregulin 1 Type I Overexpression Is Associated with Reduced NMDA Receptor-Mediated Synaptic Signaling in Hippocampal Interneurons Expressing PV or CCK.

Kotzadimitriou D, Nissen W, Paizs M, Newton K, Harrison PJ, Paulsen O, Lamsa K.

eNeuro. 2018 May 8;5(2). pii: ENEURO.0418-17.2018. doi: 10.1523/ENEURO.0418-17.2018. eCollection 2018 Mar-Apr.

11.

Dynamic ErbB4 Activity in Hippocampal-Prefrontal Synchrony and Top-Down Attention in Rodents.

Tan Z, Robinson HL, Yin DM, Liu Y, Liu F, Wang H, Lin TW, Xing G, Gan L, Xiong WC, Mei L.

Neuron. 2018 Apr 18;98(2):380-393.e4. doi: 10.1016/j.neuron.2018.03.018. Epub 2018 Apr 5.

PMID:
29628188
12.

A Genetic Study of Psychosis in Huntington's Disease: Evidence for the Involvement of Glutamate Signaling Pathways.

Tsuang DW, Greenwood TA, Jayadev S, Davis M, Shutes-David A, Bird TD.

J Huntingtons Dis. 2018;7(1):51-59. doi: 10.3233/JHD-170277.

PMID:
29480208
13.

Neuregulin directed molecular mechanisms of visual cortical plasticity.

Grieco SF, Holmes TC, Xu X.

J Comp Neurol. 2019 Feb 15;527(3):668-678. doi: 10.1002/cne.24414. Epub 2018 Mar 9. Review.

PMID:
29464684
14.

Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex.

Wang YN, Figueiredo D, Sun XD, Dong ZQ, Chen WB, Cui WP, Liu F, Wang HS, Li HW, Robinson H, Fei EK, Pan BX, Li BM, Xiong WC, Mei L.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2508-2513. doi: 10.1073/pnas.1716322115. Epub 2018 Feb 20.

15.

An essential role for neuregulin-4 in the growth and elaboration of developing neocortical pyramidal dendrites.

Paramo B, Wyatt S, Davies AM.

Exp Neurol. 2018 Apr;302:85-92. doi: 10.1016/j.expneurol.2018.01.002. Epub 2018 Jan 6.

16.

A Novel Ultrasensitive In Situ Hybridization Approach to Detect Short Sequences and Splice Variants with Cellular Resolution.

Erben L, He MX, Laeremans A, Park E, Buonanno A.

Mol Neurobiol. 2018 Jul;55(7):6169-6181. doi: 10.1007/s12035-017-0834-6. Epub 2017 Dec 20.

17.

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia.

Mostaid MS, Lee TT, Chana G, Sundram S, Shannon Weickert C, Pantelis C, Everall I, Bousman C.

Front Psychiatry. 2017 Nov 6;8:225. doi: 10.3389/fpsyt.2017.00225. eCollection 2017.

18.

BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia.

Zhang Z, Huang J, Shen Y, Li R.

Front Mol Neurosci. 2017 Sep 25;10:302. doi: 10.3389/fnmol.2017.00302. eCollection 2017. Review.

19.

Neuregulin signaling pathway in smoking behavior.

Gupta R, Qaiser B, He L, Hiekkalinna TS, Zheutlin AB, Therman S, Ollikainen M, Ripatti S, Perola M, Salomaa V, Milani L, Cannon TD, Madden PAF, Korhonen T, Kaprio J, Loukola A.

Transl Psychiatry. 2017 Aug 22;7(8):e1212. doi: 10.1038/tp.2017.183.

20.

Corrigendum to "Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population" [Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 36 (2012) 17-21].

Chen P, Chen J, Huang K, Ji W, Wang T, Li T, Wang Y, Wang H, He L, Feng G, Shi Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:501. doi: 10.1016/j.pnpbp.2017.07.018. Epub 2017 Aug 10. No abstract available.

PMID:
28803680

Supplemental Content

Loading ...
Support Center